Effects of menthol on tobacco smoke exposure, nicotine dependence, and NNAL glucuronidation

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 1, 2009, Pages 35-41

  Muscat, Joshua E ^a,c   Chen, Gang ^a   Knipe, Ashley ^a   Stellman, Steven D ^b   Lazarus, Philip ^a   Richie Jr , John P ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

^b Columbia University ^*  (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (N NITROSOMETHYLAMINO) 1 (3PYRIDYL) 1 BUTANOL; BIOLOGICAL MARKER; BUTANOL; CARCINOGEN; COTININE; MENTHOL; THIOCYANATE; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; ETHNIC DIFFERENCE; FEMALE; GLUCURONIDATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER MICROSOME; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION EXPOSURE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; TOBACCO DEPENDENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; COTININE; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCURONATES; HUMANS; MALE; MENTHOL; NITROSAMINES; REGRESSION ANALYSIS; THIOCYANATES; TOBACCO SMOKE POLLUTION; TOBACCO USE DISORDER;

EID: 58349090455     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0744     Document Type: Article

References (46)

1. Paschke T, Scherer G, Heller WD. Effects of ingredients on cigarette smoke composition and biological activity: a literature overview. Beitr Tabakforsch Int 2002;20:107-247.
2. Rodgman A. Some studies of the effects of additives on cigarette mainstream smoke properties. I. Flavorants. Beitr Tabakforsch Int 2002;20:83-103.
3. Baker RR, Massey ED, Smith G. An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem Toxicol 2004;42 Suppl:S53-83.
4. Werley MS, Coggins CR, Lee PN. Possible effects on smokers of cigarette mentholation: a review of the evidence relating to key research questions. Regul Toxicol Pharmacol 2007;47:189-203.
5. Garten S, Falkner RV. Role of mentholated cigarettes in increased nicotine dependence and greater risk of tobacco-attributable disease. Prev Med 2004;38:793-8.
6. Hebert JR, Kabat GC. Menthol cigarette smoking and oesophageal cancer. Int J Epidemiol 1989;18:37-44.
7. Kabat GC, Hebert JR. Use of mentholated cigarettes and lung cancer risk. Cancer Res 1991;51:6510-3.
8. Sydney S, Tekawa IS, Friedman GD, Sadler MC, Tashkin DP. Mentholated cigarette use and lung cancer. Arch Intern Med 1995;55:727-32.
9. Carpenter CL, Jarvik ME, Morgenstern H, McCarthy WJ, London SJ. Mentholated cigarette smoking and lung-cancer risk. Ann Epidemiol 1999;9:114-20.
10. Brooks DR, Palmer JR, Strom BL, Rosenberg L. Menthol cigarettes and risk of lung cancer. Am J Epidemiol 2003;158:609-16.
11. Stellman SD, Chen Y, Muscat JE, et al. Lung cancer risk in white and black Americans. Ann Epidemiol 2003;13:294-302.
12. Kreslake JM, Wayne GF, Alpert HR, Koh HK, Connolly GN. Tobacco industry control of menthol in cigarettes and targeting of adolescents and young adults. Am J Public Health 2008;98:1685-92.
13. Azzi C, Zhang J, Purdon CH et al. Permeation and reservoir formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene (B[a]P) across porcine esophageal tissue in the presence of ethanol and menthol. Carcinogenesis 2006;27:137-45.
14. Benowitz NL, Herrera B, Jacob P 3rd. Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther 2004;310:1208-15.
15. Henningfield JE, Benowitz NL, Ahijevych K, Garrett BE, Connolly GN, Wayne GF. Does menthol enhance the addictiveness of cigarettes? An agenda for research. Nicotine Tob Res 2003;5:9-11.
16. Hyland A, Garten S, Giovino GA, Cummings KM. Mentholated cigarettes and smoking cessation: findings from COMMIT. Community Intervention Trial for Smoking Cessation. Tob Control 2002;11:135-9.
17. Muscat JE, Richie JP, Jr., Stellman SD. Mentholated cigarettes and smoking habits in whites and blacks. Tob Control 2002;11:368-71.
18. Harris KJ, Okuyemi KS, Catley D, Mayo MS, Ge B, Ahluwalia JS. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion. Prev Med 2004;38:498-502.
19. Pletcher MJ, Hulley BJ, Houston T, Kiefe CI, Benowitz N, Sidney S. Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arch Intern Med 2006;166:1915-22.
20. Okuyemi KS, Faseru B, Sanderson Cox L, Bronars CA, Ahluwalia JS. Relationship between menthol cigarettes and smoking cessation among African American light smokers. Addiction 2007;102:1979-86.
21. Fu SS, Okuyemi KS, Partin MR, et al. Menthol cigarettes and smoking cessation during an aided quit attempt. Nicotine Tob Res 2008;10:457-62.
22. Giovino GA, Sidney S, Gfroerer JC, et al. Epidemiology of menthol cigarette use. Nicotine Tob Res 2004;6 Suppl 1:S67-81.
23. Clark PI, Gardiner PS, Djordjevic MV, Leischow SJ, Robinson RG. Menthol cigarettes: setting the research agenda. Nicotine Tob Res 2004;6 Suppl 1:S5-9.
24. Richie JP, Jr., Carmella SG, Muscat JE, Scott DG, Akerkar SA, Hecht SS. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev 1997;6:783-90.
25. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119-27.
26. Wiener D, Fang JL, Dossett N, Lazarus P. Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone glucuronidation phenotype in human liver microsomes. Cancer Res 2004;64:1190-6.
27. Coughtrie MW, Burchell B, Bend JR. A general assay for UDP glucuronosyltransferase activity using polar amino-cyano stationary phase HPLC and UDP[U-14C]glucuronic acid. Anal Biochem 1986;159:198-205.
28. Chen G, Dellinger RW, Sun D, Spratt TE, Lazarus P. Glucuronidation of tobacco-specific nitrosamines by UGT2B10. Drug Metab Dispos 2008;36:824-30.
29. Muscat JE, Djordjevic MV, Colosimo S, Stellman SD, Richie JP, Jr. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer 2005;103:1420-6.
30. Friedman GD, Sadler M, Tekawa IS, Sidney S. Mentholated cigarettes and non-lung smoking related cancers in California, USA. J Epidemiol Community Health 1998;52:202.
31. Murray RP, Connett JE, Skeans MA, Tashkin DP. Menthol cigarettes and health risks in Lung Health Study data. Nicotine Tob Res 2007;9:101-7.
32. Stoner GD, Shimkin MB, Kniazeff AJ, Weisburger JH, Weisburger EK, Gori GB. Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice. Cancer Res 1973;33:3069-85.
33. Ahijevych K, Garrett BE. Menthol pharmacology and its potential impact on cigarette smoking behavior. Nicotine Tob Res 2004;6 Suppl 1:S17-28.
34. Clark PI, Gautam S, Gerson LW. Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers. Chest 1996;110:1194-8.
35. Ahijevych K, Gillespie J. Nicotine dependence and smoking topography among black and white women. Res Nurs Health 1997;20:505-14.
36. Jarvik ME, Tashkin DP, Caskey NH, McCarthy WJ, Rosenblatt MR. Mentholated cigarettes decrease puff volume of smoke and increase carbon monoxide absorption. Physiol Behav 1994;56:563-70.
37. Caraballo RS, Giovino GA, Pechacek TF, et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA 1998;280:135-9.
38. Collins CC, Moolchan ET. Shorter time to first cigarette of the day in menthol adolescent cigarette smokers. Addict Behav 2006;31:1460-4.
39. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989;84:791-9.
40. Ren Q, Murphy SE, Zheng Z, Lazarus P. O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9. Drug Metab Dispos 2000;28:1352-60.
41. Lazarus P, Zheng Y, Aaron Runkle E, Muscat JE, Wiener D. Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes. Pharmacogenet Genomics 2005;15:769-78.
42. Chen G, Blevins-Primeau AS, Dellinger RW, Muscat JE, Lazarus P. Glucuronidation of nicotine and cotinine by UGT2B10: loss of function by the UGT2B10 Codon 67 (Asp>Tyr) polymorphism. Cancer Res 2007;67:9024-9.
43. Bhasker CR, McKinnon W, Stone A, et al. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics 2000;10:679-85.
44. Jin C-J, Miners JO, Lillywhite KJ, Mackenzie PI. Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ther 1993;264:475-9.
45. Ritter JK, Sheen YY, Owens IS. Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. J Biol Chem 1989;265:7900-6.
46. Devlin RB, Frampton ML, Ghio AJ. In vitro studies: what is their role in toxicology? Exp Toxicol Pathol 2005;57:183-8.